<i>N</i> ‐acetylcysteine as a new prominent approach for treating psychiatric disorders
نویسندگان
چکیده
N-acetylcysteine (NAC) is a well-known and safe mucolytic agent, also used in patients with paracetamol overdose. In addition to these effects, recent preclinical clinical studies have shown that NAC exerts beneficial effects on different psychiatric disorders. Many potential mechanisms been proposed underlie the therapeutic of NAC, including regulation several neurotransmitters, oxidative homeostasis, inflammatory mediators. this paper, we summarize current knowledge ability ameliorate symptoms neuropathologies related disorders, attention deficit hyperactivity disorder, anxiety, bipolar depression, obsessive–compulsive obsessive–compulsive-related posttraumatic stress schizophrenia. Although positive effect animal models efficacy not fully established. remains strong candidate for adjunct treatment many but additional are needed.
منابع مشابه
a new approach to credibility premium for zero-inflated poisson models for panel data
هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...
15 صفحه اولTreating Psychiatric Disorders with Care
Psychiatry is the branch of medicine that deals with diagnosis, prevention, and treatment of mental disorders related to behaviour, cognition, mood, perceptions, etc. Journal of Psychiatry is an open access peer reviewed international journal that provides a platform for the Researchers of Psychiatry discipline to publish innovative ideas in Psychiatry and outcomes of their research in all the ...
متن کاملNeurotechnology: a new approach for treating brain disorders.
Advances in neuroscience, engineering and computer technologies are creating opportunities to connect the brain directly to devices to treat a variety of disorders, both neurological and psychiatric. They are opening a new field of neuroscience called "neurotechnology." This article reviews efforts in this area that are ongoing at Brown University and the hospitals affiliated with Brown's Alper...
متن کاملGenus Boswellia as a new candidate for neurodegenerative disorders
Neurodegenerative diseases, characterized by progressive loss of neurons, share common mechanisms such as apoptotic cell death, mitochondrial dysfunction, inflammation, and oxidative stress. Genus Boswellia is a genus in the Burseraceae family. It comprises several species traditionally used for treatment of chronic inflammatory diseases, cerebral edema, chronic pain syndrome, gastrointestinal d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Pharmacology
سال: 2021
ISSN: ['0007-1188', '1476-5381']
DOI: https://doi.org/10.1111/bph.15456